Compare MASS & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MASS | AOMR |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.6M | 218.7M |
| IPO Year | 2020 | 2019 |
| Metric | MASS | AOMR |
|---|---|---|
| Price | $6.66 | $9.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $12.00 | $11.08 |
| AVG Volume (30 Days) | ★ 225.8K | 56.4K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.94% |
| EPS Growth | ★ 125.47 | 53.85 |
| EPS | 0.54 | ★ 1.80 |
| Revenue | ★ $56,197,000.00 | N/A |
| Revenue This Year | $19.44 | N/A |
| Revenue Next Year | $18.63 | $1.38 |
| P/E Ratio | $12.52 | ★ $5.09 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.20 | $7.96 |
| 52 Week High | $9.34 | $10.21 |
| Indicator | MASS | AOMR |
|---|---|---|
| Relative Strength Index (RSI) | 44.08 | 61.36 |
| Support Level | $5.86 | $8.64 |
| Resistance Level | $6.66 | $9.22 |
| Average True Range (ATR) | 0.34 | 0.15 |
| MACD | -0.08 | 0.03 |
| Stochastic Oscillator | 0.44 | 80.14 |
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.